Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 35, 2018 - Issue 11
166
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Circadian rhythms may not influence the outcomes of thrombolysis in patients with ischemic stroke: A study from China

ORCID Icon, , ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 1533-1542 | Received 28 May 2018, Accepted 26 Jun 2018, Published online: 11 Jul 2018

References

  • Beker MC, Caglayan B, Yalcin E, Caglayan AB, Turkseven S, Gurel B, Kelestemur T, Sertel E, Sahin Z, Kutlu S, et al. 2018. Time-of-day dependent neuronal injury after ischemic stroke: Implication of circadian clock transcriptional factor Bmal1 and survival kinase AKT. Mol Neurobiol. 55:2565–76.
  • Cappellari M, Bovi P, Moretto G. 2014. Circadian variation in the effect of intravenous thrombolysis after non-lacunar stroke. J Thromb Thrombolysis. 38:253–59.
  • Chaturvedi S, Adams HP, Woolson RF. 1999. Circadian variation in ischemic stroke subtypes. Stroke. 30:1792–95.
  • Cheung RT, Mak W, Chan KH. 2001. Circadian variation of stroke onset in Hong Kong Chinese: A hospital-based study. Cerebrovasc Dis. 12:1–6.
  • Elliott WJ. 1998. Circadian variation in the timing of stroke onset: A meta-analysis. Stroke. 29:992–96.
  • Gökçal E, Niftaliyev E, Asil T. 2017. Etiological classification of ischemic stroke in young patients: A comparative study of TOAST, CCS, and ASCO. Acta Neurol Belg. 117:643–48.
  • Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von KR, Boysen G, Bluhmki E, Höxter G, Mahagne MH. 1995. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 274:1017–25.
  • Hallevi H, Albright KC, Martin-Schild SB, Barreto AD, Morales MM, Bornstein N, Ifejika NL, Shuaib A, Grotta JC, Savitz SI. 2009. Recovery after ischemic stroke: Criteria for good outcome by level of disability at day 7. Cerebrovasc Dis. 28:341–48.
  • Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J. 1990. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiol Int. 7:203–16.
  • Helsinki Stroke Thrombolysis Registry Group. 2012. Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland. Int J Stroke. 7:511–16.
  • Ibrahim F, Akhtar N, Salam A, Kamran S, Deleu D, D’Souza A, Imam Y, Bourke P, Joseph S, Santos M, et al. 2016. Stroke thrombolysis protocol shortens “Door-to-Needle Time” and improves outcomes: Experience at a tertiary care center in Qatar. J Stroke Cerebrovasc Dis. 25:2043–46.
  • Iranzo A, Santamaría J, Berenguer J, Sánchez M, Chamorro A. 2002. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology. 58:911–16.
  • Jauss M, Schütz HJ, Tanislav C, Misselwitz B, Rosenow F. 2010. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy. Eur J Neurol. 17:555–61.
  • Kasner SE. 2006. Clinical interpretation and use of stroke scales. Lancet Neurol. 5:603–2.
  • Kerr DM, Fulton RL, Lees KR. 2012. Seven-day NIHSS is a sensitive outcome measure for exploratory clinical trials in acute stroke: Evidence from the Virtual International Stroke Trials Archive. Stroke. 43:1401–03.
  • Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N. 2011. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke. 42:1638–43.
  • Kõrv J, Vibo R, Kadlecová P, Kobayashi A, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Fekete K, Demarin V, et al. 2014. Benefit of thrombolysis for stroke is maintained around the clock: Results from the SITS-EAST registry. Eur J Neurol. 21:112–17.
  • Lorenzano S, Ahmed N, Tatlisumak T, Gomis M, Dávalos A, Mikulik R, Sevcik P, Ollikainen J, Wahlgren N, Toni D. 2014. Within-day and weekly variations of thrombolysis in acute ischemic stroke: Results from safe implementation of treatments in stroke-international stroke thrombolysis register. Stroke. 45:176–84.
  • Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA. 1989. Morning increase in onset of ischemic stroke. Stroke. 20:473–76.
  • Mikulik R, Ribo M, Hill MD, Grotta JC, Malkoff M, Molina C, Rubiera M, Delgado-Mederos R, Alvarez-Sabin J, Alexandrov AV. 2007. Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation. 115:2660–65.
  • Omama S, Yoshida Y, Ogawa A, Onoda T, Okayama A. 2006. Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psych. 77:1345–49.
  • Ovbiagele B, Saver JL. 2010. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis. 29:50–56.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16:151–66.
  • Rhoney DH, Coplin WM, Lin Y, Frankel M, Lyden PD, Levine SR. 2010. Time of day, outcome, and response to thrombolytic therapy: The National Institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke trial experience. J Stroke Cerebrovasc Dis. 19:40–48.
  • Sander D, Klingelhöfer J. 1993. Circadian blood pressure patterns in four cases with hemodynamic brain infarction and prolonged blood-brain barrier disturbance. Clin Neurol Neurosurg. 95:221–29.
  • Scheer FA, Shea SA. 2014. Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle. Blood. 123:590–93.
  • Vilas D, Gomis M, Blanco M, Cortés J, Millán M, de la Ossa NP, Dorado L, López-Cancio E, Suñol A, Dávalos A. 2012. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion. Chronobiol Int. 29:1383–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.